25 Posts Not to Miss from SABCS 2025
European Commission Welcomes Political Agreement on Major Reform of EU Pharmaceutical Rules
Bristol Myers Squibb’s Opdivo-Plus-Chemotherapy Regimen for Classical Hodgkin Lymphoma Receives FDA Priority Review
Maintenance Therapy After First-Line Therapy for Ovarian Cancer - ACS Journals
Stephen Miller's Message as Executive Director Upon Leaving Cedars-Sinai
Tinengotinib in Previously Treated Cholangiocarcinoma: New Signals from a Multicentre Phase 2 Trial
Hedley Lewis: A New Research Hub to Transform Paediatric Cancer Care in South Africa
